Anxiety Resources – Myself

Overview

Some people seem to move through the world with an unusually sensitive internal alarm system. Their brain anticipates danger, their body prepares to respond, and it can take a long time for the feeling to settle. You might recognise that pattern from early childhood: worrying about things that other people barely notice, feeling tense even when life is going well, or finding ordinary uncertainty surprisingly difficult to tolerate.

This page is about longstanding, primary anxiety conditions—not the temporary anxiety that can accompany bereavement, financial hardship, acute illness or another obvious external crisis. Anxiety can be a persistent feature of how your brain and body process information, even when nothing particularly threatening is happening around you.

The experience takes different forms. You might worry about many possible future problems (generalised anxiety), experience sudden episodes of intense bodily alarm (panic disorder), anticipate scrutiny or embarrassment around people (social anxiety), fear situations where escape seems difficult (agoraphobia), or have a strong and persistent response to particular situations (specific phobias). These can overlap without being biologically identical.

There is substantial genetic evidence for inherited differences in threat-response systems. A February 2026 study of 122,341 people with anxiety disorders and 729,881 controls identified 58 associated genetic regions and prioritised 66 genes with multiple forms of biological support. The findings particularly implicated GABA-related inhibitory signalling, along with other neuronal and molecular pathways (Strom et al., Nature Genetics, 2026).

The good news is that we have effective ways to change how these systems respond. Exposure-based interventions, cognitive behavioural therapy (CBT), certain medicines and targeted self-management techniques can substantially reduce symptoms. Understanding your particular anxiety profile is a useful first step toward choosing approaches that improve your life.

On this page: Early warning signs · How to get diagnosed? · Life trajectory · Things you might need to work on · Workplace success · Family dynamics · Friendship & social skills · Intimate relationships · Self-help & coping · How it can be for Them to interact with You · Learn more (the Science) · Organisations · Resources · Other people like you

Early warning signs

For many people, persistent anxiety is familiar long before they seek an assessment. Perhaps you were a child who worried about school, health or separation from family when everyone else seemed relaxed. You may have avoided speaking in groups, anticipated every possible difficulty before an outing, or experienced stomach aches and muscle tension that became part of everyday life.

Signs of a longstanding anxiety pattern can include:

• Anticipating problems constantly. Your mind quickly notices what might go wrong, even when the probability is small.
• Difficulty switching off. A problem may feel urgent until you have examined several possible outcomes, and then your attention moves to another concern.
• Physical arousal. Restlessness, tense muscles, sweating, trembling, a racing heart, stomach discomfort or waking already feeling alert.
• Persistent avoidance. Turning down invitations, postponing decisions, avoiding travel, or choosing familiar settings because unfamiliar ones bring too much anxiety.
• Social anticipation. Rehearsing conversations, worrying how you are perceived, or reviewing interactions afterward.
• Panic sensations. Sudden episodes of intense bodily alarm, sometimes with fear that you will faint, lose control, become trapped or have another attack.
• Reassurance or safety routines. Repeatedly checking forecasts, travel arrangements or other information to reduce uncertainty.

The pattern matters more than any single symptom. People differ considerably: someone with generalised anxiety may rarely have panic attacks, while someone with panic disorder can feel relatively comfortable between episodes but restrict their life to avoid another attack.

Notice whether you are organising your choices around preventing anxiety rather than around what you actually want to do. That distinction can become particularly clear when you decline a promising job, relationship, trip or social opportunity despite wanting it.

How to get diagnosed?

An assessment should identify what kind of anxiety you experience, when it began, how your body responds, and how it changes your everyday decisions. A good evaluation also examines whether more than one anxiety profile is present.

The main patterns are:

• Generalised anxiety: Frequent, difficult-to-control worry across several areas of life, often accompanied by tension, restlessness, concentration difficulties, irritability, sleep disruption or fatigue.
• Panic disorder: Recurrent panic attacks—sudden episodes of intense fear or physical alarm—followed by concern about further attacks or changes in behaviour to avoid them.
• Social anxiety: Strong and persistent fear of being judged or embarrassed in social or performance situations, often leading to avoidance or prolonged anticipation.
• Agoraphobia: Anxiety about being in situations where escape or obtaining help might seem difficult, such as public transport, crowds, open spaces or being away from home.
• Specific phobias: Marked fear and avoidance centred on a particular object or situation, such as flying, heights, animals or medical procedures.

The clinician should ask about how much time anxiety occupies, what you avoid, which physical sensations you experience, and what you would like to be able to do. Short questionnaires such as the GAD-7 can measure recent symptoms, but an individual score does not explain your entire profile or establish the cause.

It is also worth checking whether thyroid disorders, heart rhythm problems, medication effects, stimulant use, sleep disorders or other medical conditions contribute to your symptoms. This does not change the strong biological evidence for chronic anxiety; it helps identify what needs to be addressed in your particular situation.

Genomic studies, brain imaging and physiological measurements have identified many anxiety-associated signatures. They are not yet combined into a universally validated diagnostic test for an individual. An assessment can nevertheless lead to treatment now, with progress measured through symptoms and regained functioning.

Life trajectory

Longstanding anxiety can persist for many years, with periods of improvement and recurrence. Generalised anxiety and social anxiety often follow a chronic course without treatment. Some people become increasingly restricted by avoidance, while others manage successful lives at the cost of considerable internal effort.

This can have serious consequences. A 2026 clinical review reported that only about 40% of primary-care patients with generalised or social anxiety fully recovered over two to five years in the studies reviewed. In a trial of treatment options cited by that review, 51% of those offered a choice of CBT, medication or both achieved remission at one year, compared with 33% receiving usual care (JAMA Internal Medicine, 2026).

Importantly, improvements can last. A 2025 follow-up of 355 people who had received exposure-based CBT for anxiety disorders found that gains in anxiety and psychosocial functioning were largely maintained at five years. From the six-month to five-year assessments, 4.9% showed reliable relapse and 6.5% achieved new reliable remission. Only 58% of those eligible provided the long-term follow-up, so the results are most informative about participants who remained in the study (2025 five-year exposure follow-up).

Physical health matters too. A 2026 analysis of 165 studies reported increased mortality and suicide-related risks in several anxiety and stress-related conditions. For generalised anxiety disorder, pooled natural-cause mortality was 1.55 times that of comparison populations, although observational findings cannot establish that anxiety directly caused every difference (2026 mortality meta-analysis).

Your trajectory is not limited to whether you feel anxious. Being able to travel, maintain friendships, make decisions, sleep, work and enjoy intimacy may matter just as much. Successful treatment can mean that anxiety occurs less often, becomes less intense, or stops determining your choices.

Things you might need to work on

Persistent anxiety tends to influence both what you notice and what you do in response. Working on these patterns can gradually create more room for the life you want.

• Separating realistic planning from endless anticipation. Planning for a problem can be useful. Repeatedly analysing an unlikely outcome after you have made a reasonable plan may add little protection.
• Tolerating uncertainty. Practise decisions where you cannot know every result in advance. Begin with situations that are manageable but personally meaningful.
• Recognising avoidance. Keep track of activities you have stopped doing or opportunities you have declined mainly because of anticipated anxiety.
• Learning your bodily pattern. Notice what happens to breathing, heart rate, digestion, muscles and sleep when you feel threatened. For panic, learning to experience these sensations without treating them as emergencies can be central to treatment.
• Reducing repeated reassurance. If asking someone the same question brings brief relief but does not settle the worry, it may be more useful to work on how you respond to uncertainty.
• Making room for recovery. Intense vigilance is tiring. Regular sleep, activity and time away from demanding tasks support general health, although they are not substitutes for effective anxiety treatment.

It can help to choose a measurable goal, such as taking public transport twice a week, speaking in meetings, sleeping more consistently or making a decision without prolonged checking. Measure what you are doing differently, not only how calm you feel at a particular moment.

Workplace success

Anxiety can affect careers in two distinct ways. It may interfere directly with concentration, sleep, communication or decision-making. It may also affect which opportunities you take in the first place.

You might work long hours because you repeatedly check for mistakes, avoid presentations, decline promotions that involve travel, or become exhausted by anticipating criticism. You may be excellent at noticing risks and planning carefully, yet find that the same sensitivity slows decisions or makes it difficult to delegate.

These effects appear in employment research. A 2025 longitudinal study of 250 job-seekers with social anxiety disorder found that greater social anxiety symptoms predicted fewer hours worked later in the study. A separate 2026 US health-survey analysis of 75,261 adults found greater work-productivity loss and everyday activity impairment among people with likely or diagnosed generalised anxiety than among those without it (Losiewicz et al., Psychiatric Research and Clinical Practice, 2025; 2026 US health-survey study, Journal of Affective Disorders).

Different anxiety profiles need different adjustments:

• Generalised anxiety: Set a reasonable decision deadline, clarify what level of checking a task requires, and distinguish essential risk assessment from repeated hypothetical worry.
• Social anxiety: Practise presentations, meetings or difficult conversations through gradual exposure. Rehearsal can be helpful; endless preparation can become another way of postponing action.
• Panic and agoraphobia: Gradually regain access to commuting, travel, meetings or public spaces using an exposure plan rather than avoiding every possible trigger.
• Physical arousal and sleep difficulties: Review the demands of particular roles and whether treatment or sensible scheduling changes would improve performance.

If you need an accommodation, you can describe a practical requirement—clear priorities, a predictable schedule, advance notice of major tasks, or a quieter workspace—without disclosing everything about your health.

Career progress may involve taking manageable risks and accepting that a certain amount of anxiety can accompany meaningful opportunities. A good treatment goal is not simply feeling calm before every meeting; it is being able to participate in the meeting and do your work even when some anxiety remains.

Family dynamics

Longstanding anxiety can run in families because there is a substantial inherited component. Relatives may share patterns of vigilance, social sensitivity, worry or physical arousal, even if they experience them differently.

Family life can gradually adapt to one person’s anxiety. Someone may repeatedly reassure you, make telephone calls on your behalf, organise travel to minimise uncertainty or avoid activities you find difficult. These arrangements can be useful in the short term but may also shrink your opportunities to become more comfortable with the situations you want to manage.

You might worry intensely about the wellbeing of a partner, child or parent, asking for frequent updates or imagining emergencies. People close to you may experience the concern as affection at first, then begin to feel monitored or restricted.

It helps to tell people what anxiety actually feels like for you. You might explain that your body often reacts before you have consciously decided something is dangerous, or that uncertainty can stay active in your mind for hours. Then discuss specific arrangements: what kind of information is genuinely helpful, which reassurance patterns have become repetitive, and what activities you want to reclaim.

If you are parenting, notice whether your own anticipation of danger is limiting your child’s independence. You can remain attentive to real safety while allowing age-appropriate exploration and learning. If anxiety is affecting family life significantly, an appropriately trained clinician can involve family members in treatment if you want them included.

Friendship & social skills

You may genuinely want friendships but find them unusually effortful. A social invitation involves anticipating the journey, possible awkward moments, conversation topics, other people’s reactions and the way you might feel afterward. Saying no may bring immediate relief, even though you later feel disappointed or lonely.

Some people experience especially intense social anxiety: worrying that they will sound foolish, blush, freeze, say the wrong thing or be judged. Others are comfortable in conversation but reluctant to commit to unfamiliar activities, travel or spontaneous plans. After meeting friends, you may replay the interaction and focus on details that nobody else noticed.

This can create a difficult cycle: the fewer social experiences you have, the fewer opportunities your brain gets to learn that most ordinary interactions are manageable. Gradual, repeated contact is often more useful than waiting until you feel completely ready.

Start with activities you actually enjoy. A short walk or meeting around a shared interest may be easier than an unstructured social event. If you cancel often, let people know what is happening and suggest a realistic alternative. Rebuilding friendships can become a concrete goal for therapy.

Your friends may appear to decide, speak and act with little hesitation. That difference can feel enormous from the inside. Anxiety treatment can help you participate more freely without requiring you to become an extrovert or change your preferences about how much social contact you enjoy.

Intimate relationships

Chronic anxiety can affect dating, physical closeness, sex, commitment and everyday partnership. The effects are not always obvious. You may spend more time anticipating rejection or abandonment than enjoying the relationship itself, or interpret small changes in a partner’s expression, tone or availability as signs that something is wrong.

If you experience social anxiety, beginning a relationship can be particularly difficult. Initiating a conversation, expressing attraction, asking someone out or talking about sex may feel much more exposing than it does to other people.

In an established relationship, you may ask for reassurance frequently, avoid unfamiliar experiences together, or need unusually detailed plans before travelling or socialising. A partner may become tired of repeated hypothetical discussions, even when the underlying worries feel urgent to you.

Anxiety also influences sexual functioning. Physical arousal associated with fear can interfere with desire, erections, lubrication, orgasm or your ability to stay engaged with a partner. Anticipating difficulty can become its own source of anxiety. SSRIs and SNRIs, although effective for some anxiety conditions, can also affect libido and orgasm. These effects deserve explicit discussion when reviewing treatment, rather than being silently accepted.

It helps to speak plainly about what you need and what your partner is experiencing. You can ask for support with a particular situation while keeping responsibility for your own treatment. Both people need space for affection, independence, disagreement and consent. If anxiety has begun to organise the entire relationship, addressing the anxiety directly may improve life for both of you.

Self-help & coping

Treatments with the strongest clinical evidence

Cognitive behavioural therapy (CBT) is an effective treatment for several chronic anxiety profiles. It is more than discussing why you feel worried. A good programme identifies the predictions, avoidance patterns, physical responses and habits that maintain anxiety, then helps you practise different responses in real situations.

For generalised anxiety, treatment often includes reducing repetitive worry, changing unhelpful interpretations of uncertainty and testing feared predictions. A network meta-analysis of 65 randomised trials involving 5,048 adults found that CBT reduced anxiety symptoms compared with usual care by an average standardised difference of 0.74, with evidence of benefit continuing after treatment (Papola et al., JAMA Psychiatry, 2023).

For social anxiety, treatment often involves gradually entering situations you have avoided, shifting attention away from constant self-monitoring and testing feared social predictions. For panic disorder, treatment can include interoceptive exposure—safely practising feared bodily sensations under professional guidance so they become less threatening. For phobias and agoraphobia, gradual exposure to relevant situations is central.

There are now promising digital options. In a 2025 randomised trial involving 351 adults with generalised anxiety, a tailored smartphone-based CBT programme produced substantially greater improvements than online psychoeducation. At ten weeks, 71.0% of assessed participants in the digital treatment group met the trial’s clinician-rated remission criterion, compared with 34.6% in the comparison group; benefits remained at 24 weeks. The programme, assessment method and selected population are important when interpreting those rates (JAMA Network Open, 2025).

Medication

SSRIs and SNRIs are established medication options for generalised anxiety and several other anxiety conditions. They can reduce the intensity and frequency of anxiety, although the degree of improvement and side effects differ between people. A clinician can help choose and review an appropriate trial. If medication is effective, continuing treatment for a period after remission can reduce relapse risk (Agency for Care Effectiveness, GAD guidance, 2025).

Other medicines may be considered in particular circumstances. Benzodiazepines act rapidly on GABA-related signalling but carry important dependence, sedation, memory and withdrawal risks. They are generally not a good routine long-term first choice for persistent anxiety. Choice of medication should also consider sleep, cardiovascular health, interactions and sexual functioning.

Anxiety is biologically heterogeneous. If the first intervention has little benefit, it is worth reviewing the anxiety subtype, treatment dose and duration, the actual behavioural techniques used and any side effects before deciding what to do next.

Practical things you can do

• Identify one meaningful activity you have been avoiding and plan a manageable first step back into it.
• Practise noticing when worry has stopped producing new information. Return to the task or activity you chose instead of continuing the same analysis.
• If panic is part of your pattern, learn about bodily sensations and discuss structured interoceptive exposure with a trained professional.
• Use sleep, physical activity and ordinary relaxation to support health and recovery without treating them as replacements for proven anxiety treatment.
• Reduce unnecessary stimulant exposure if caffeine or other stimulants noticeably worsen your physical symptoms.
• Track real changes: journeys taken, conversations initiated, opportunities accepted, decisions completed and time regained.

What has weaker or less consistent evidence?

Mindfulness, meditation, breathwork and yoga may improve distress or general wellbeing. Their value depends on the intervention and the anxiety profile. In a randomised study, Kundalini yoga improved generalised anxiety compared with stress education but was not shown to be as effective as CBT (Simon et al., JAMA Psychiatry, 2020).

Relaxation therapy shows some short-term benefit, but results are less convincing after excluding lower-quality studies, and sustained benefits have been more consistently demonstrated for CBT. Supplements marketed for anxiety, unregulated neurostimulation devices and vagus-nerve techniques should not be assumed to have established long-term efficacy for primary chronic anxiety simply because they affect plausible physiological pathways.

If you experience sudden new chest pain, fainting, severe breathlessness or another concerning physical symptom, seek appropriate medical assessment rather than assuming it must be anxiety. If you feel unable to stay safe or are experiencing thoughts of suicide, use local emergency services or Relatix Health’s urgent support page.

How it can be for Them to interact with You

People close to you may see an intelligent, thoughtful person who repeatedly imagines bad outcomes, hesitates over decisions or finds apparently simple situations unusually demanding. They might be surprised when a small uncertainty produces a strong physical reaction, or when you decline something you genuinely wanted to do.

Your repeated questions can feel urgent and important to you, while a partner or friend may feel that their answer never quite settles the issue. They may also find themselves avoiding experiences because of your anticipated anxiety, or spending considerable time helping you prepare for situations that they regard as ordinary.

You can make things easier by explaining what is happening in concrete terms: “I know we’ve made a reasonable plan, but my mind keeps looking for another risk,” or “Crowded places can set off a strong physical reaction; I’m working on becoming more comfortable with them.” Let people know whether you would prefer practical information, company while you practise something difficult, or a little time to settle.

You may be able to notice potential problems earlier than the people around you. At the same time, others may want spontaneity, new experiences and occasional decisions made without extensive discussion. A relationship works better when both sets of needs are visible and anxiety does not automatically have the final say.

Learn more (the Science)

Genetic architecture: a shared vulnerability with different expressions

In 2026, the Psychiatric Genomics Consortium published a GWAS meta-analysis of 122,341 cases involving generalised anxiety disorder, panic disorder, social phobia, specific phobia or agoraphobia, compared with 729,881 controls of European ancestry. The study identified 58 independent genome-wide significant variants; 51 replicated in a very large independent European-ancestry self-report sample. Functional analyses prioritised 66 genes with at least three forms of supporting evidence. Candidate pathways implicated GABAergic neurons and regulators of synaptic functioning, among other systems (Strom et al., Nature Genetics, 2026).

The signal is highly polygenic. In a UK Biobank validation, a common-variant polygenic score explained approximately 2.27% of liability variance in the European-ancestry subgroup, with lower transferability to some other ancestry groups. These results are scientifically compelling but are not, on their own, sufficiently predictive for individual diagnosis or treatment assignment.

Multiomics and cellular biology

The same 2026 study combined GWAS signals with expression quantitative trait loci, transcriptome-wide, protein-wide and methylation-wide analyses. Conservative analyses found associations involving gene-expression, protein and methylation signals in brain reference data. The functional findings implicated GABAergic inhibition alongside broader neuronal pathways; candidates included genes associated with synaptic signalling, neuronal organisation and neurodevelopment.

Anxiety regulation involves interacting amygdala–insula–prefrontal–hippocampal networks and their connections with autonomic and endocrine systems. GABA-mediated inhibition helps control neural excitability; noradrenergic signalling contributes to vigilance and sympathetic arousal; serotonin has diverse modulatory roles. Stress-hormone regulation through the hypothalamic–pituitary–adrenal axis can interact with these systems, although a single cortisol measurement does not identify a person’s anxiety subtype.

Physiological candidates under investigation include heart-rate variability, autonomic reactivity, sleep patterns, cortisol dynamics, inflammatory markers and brain functional-connectivity measures. They can reveal aspects of biology at group or subgroup level, but none is a universally established standalone diagnostic biomarker for primary chronic anxiety.

Neuroimaging and heterogeneity

A 2026 ENIGMA-Anxiety collaboration analysed MRI from 1,146 people with panic disorder and 3,778 controls across 28 sites. It found small average differences in some cortical regions and in thalamic and caudate volumes, with standardised effect sizes mostly around 0.07–0.13. The results provide evidence for structural associations while illustrating why a group-average brain difference is not automatically a clinically useful individual test (Han et al., Molecular Psychiatry, 2026).

Future biological stratification may combine common and rare genetic variation, multiomics, neuroimaging, physiological reactivity, cognitive patterns and longitudinal symptoms. A marker linked to persistent anticipatory worry may be less informative in a person whose main difficulty is panic-related interoceptive fear or social evaluation. Understanding that heterogeneity is a central goal for precision-medicine research.

Neuroplasticity and exposure-based learning

Exposure-based treatment aims to modify learned predictions about threat and coping. For panic, this may involve controlled experiences of feared bodily sensations; for social anxiety, repeated social encounters without extensive safety behaviours; for agoraphobia or phobias, entering situations previously avoided. The brain can learn new associations even when an inherited vulnerability remains.

Recent trials continue to refine the mechanisms. A 2026 randomised study involving 124 people with panic disorder or agoraphobia found that deliberately maximising fear during exposure did not improve outcomes over standard exposure, challenging the assumption that treatment must provoke the strongest possible distress to be effective (2026 randomised exposure study).

A separate 2026 randomised trial studied brief intermittent vigorous exercise as a form of interoceptive exposure for panic disorder. Compared with relaxation training, the structured exercise-based approach improved panic severity and attack frequency over follow-up, suggesting a potentially useful and relatively accessible way of retraining responses to bodily arousal. It is an adjunctive protocol requiring appropriate medical suitability, not a universal exercise prescription (Muotri et al., Frontiers in Psychiatry, 2026).

From biological research to treatment selection

Current medication choices can already take account of previous response, side effects, metabolism, other health conditions and treatment preferences. Some pharmacogenetic variants influence how the body processes individual medicines; this is distinct from having a genomic test that predicts which treatment will resolve a particular person’s anxiety.

The next step in precision medicine is prospective testing of multimodal subtypes to determine whether biological profiles improve treatment selection beyond careful clinical assessment. Established effectiveness—measured in randomised studies and meaningful everyday outcomes—remains the standard against which new biomarker-guided approaches should be assessed.

Organisations

• Anxiety & Depression Association of America (ADAA) — Research-informed information about chronic anxiety conditions, treatment and support.
• Anxiety UK — UK-based information and practical support for anxiety.
• Anxiety Canada — Accessible education and anxiety-management resources.
• National Institute of Mental Health (NIMH) — Information on anxiety symptoms, research and clinical care.

Resources

• NIMH: Anxiety disorders. Overview of major anxiety profiles and treatment approaches.
• NHS: Generalised anxiety disorder. Symptoms, assessment and treatment information.
• Anxiety Canada: Self-help resources. Skills-based material relevant to anxiety, worry and avoidance.
• ClinicalTrials.gov: Anxiety studies. Research studies, including current recruitment and eligibility information.
• Relatix Health: urgent support. Immediate next steps in a mental health crisis.

When choosing treatment, ask whether the programme has evidence for your particular anxiety profile, includes the relevant behavioural techniques, measures real-world functioning and offers a plan if the first approach provides too little benefit.

Other people like you

Someone with persistent worry, someone whose body produces sudden panic and someone who fears social scrutiny may look very different from one another. But all three may recognise the experience of a highly sensitive threat-response system shaping daily decisions and limiting opportunities.

Peer groups and condition-specific communities can help you learn how others have approached treatment, work, friendships, travel and relationships. Look for communities that exchange practical experiences and support greater independence, while respecting privacy and individual differences.

Through Relatix Health, you can follow discoveries in anxiety genetics, multiomics, biomarkers and personalised interventions. If you choose to participate in research or connect with people with related experiences, you should be able to decide what information to share and what outcomes matter most to you.